Staphylococcus aureus Infection-Related Glomerulonephritis with Dominant IgA Deposition

Int J Mol Sci. 2022 Jul 5;23(13):7482. doi: 10.3390/ijms23137482.

Abstract

Since 1995, when we reported the case of a patient with glomerulonephritis with IgA deposition that occurred after a methicillin-resistant Staphylococcus aureus (MRSA) infection, many reports of MRSA infection-associated glomerulonephritis have accumulated. This disease is being systematized as Staphylococcus infection-associated glomerulonephritis (SAGN) in light of the apparent cause of infection, and as immunoglobulin A-dominant deposition infection-related glomerulonephritis (IgA-IRGN) in light of its histopathology. This glomerulonephritis usually presents as rapidly progressive glomerulonephritis or acute kidney injury with various degrees of proteinuria and microscopic hematuria along with an ongoing infection. Its renal pathology has shown several types of mesangial and/or endocapillary proliferative glomerulonephritis with various degrees of crescent formation and tubulointerstitial nephritis. IgA, IgG, and C3 staining in the mesangium and along the glomerular capillary walls have been observed on immunofluorescence examinations. A marked activation of T cells, an increase in specific variable regions of the T-cell receptor β-chain-positive cells, hypercytokinemia, and increased polyclonal immune complexes have also been observed in this glomerulonephritis. In the development of this disease, staphylococcal enterotoxin may be involved as a superantigen, but further investigations are needed to clarify the mechanisms underlying this disease. Here, we review 336 cases of IgA-IRGN and 218 cases of SAGN.

Keywords: IgA-dominant glomerulonephritis; Staphylococcus aureus; Staphylococcus infection-associated glomerulonephritis; T-cell receptor; bacterial superantigen; cytokine; polyclonal activation; rapidly progressive glomerulonephritis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Glomerulonephritis* / pathology
  • Glomerulonephritis, IGA* / complications
  • Glomerulonephritis, IGA* / pathology
  • Humans
  • Immunoglobulin A
  • Methicillin-Resistant Staphylococcus aureus*
  • Staphylococcal Infections*
  • Staphylococcus aureus

Substances

  • Immunoglobulin A

Grants and funding

This manuscript received no specific grants from any funding agency.